Cargando…
Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer
Breast cancer screening modalities and guidelines continue to evolve and are increasingly based on risk factors, including genetic risk and a personal or family history of cancer. Here, we review genetic testing of high-penetrance hereditary breast and ovarian cancer genes, including BRCA1 and BRCA2...
Autores principales: | Willoughby, Ava, Andreassen, Paul R., Toland, Amanda Ewart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462925/ https://www.ncbi.nlm.nih.gov/pubmed/30832243 http://dx.doi.org/10.3390/jpm9010015 |
Ejemplares similares
-
The current status of risk-stratified breast screening
por: Clift, Ash Kieran, et al.
Publicado: (2021) -
Is risk-stratified breast cancer screening economically efficient in Germany?
por: Arnold, Matthias, et al.
Publicado: (2019) -
The cost-effectiveness of risk-stratified breast cancer screening in the UK
por: Hill, Harry, et al.
Publicado: (2023) -
Screening outcomes by risk factor and age: evidence from BreastScreen WA for discussions of risk‐stratified population screening
por: Noguchi, Naomi, et al.
Publicado: (2021) -
Risk‐stratified strategies in population screening for colorectal cancer
por: Lansdorp‐Vogelaar, Iris, et al.
Publicado: (2021)